Three main targets in cervical cancer care: cannabinoids ease pain by acting on CB1/CB2, TRPV1 and GPR18/55 receptors; VEGFR-targeting TKIs cut tumour blood supply; ph-sensitive peptide nanocarriers release drugs only in the tumour environment. (IMAGE)

ELSP

Three main targets in cervical cancer care: cannabinoids ease pain by acting on CB1/CB2, TRPV1 and GPR18/55 receptors; VEGFR-targeting TKIs cut tumour blood supply; ph-sensitive peptide nanocarriers release drugs only in the tumour environment.

Caption

Three main targets in cervical cancer care: cannabinoids ease pain by acting on CB1/CB2, TRPV1 and GPR18/55 receptors; VEGFR-targeting TKIs cut tumour blood supply; ph-sensitive peptide nanocarriers release drugs only in the tumour environment.

Credit

Beatrice Odei-Mensah, Samson A. Adeyemi,*, Lindokuhle M. Ngema, Hillary Mndlovu and Yahya E. Choonara*/ Faculty of Health Sciences, University of the Witwatersrand, Johannesburg 2193, South Africa

Usage Restrictions

Credit must be given to the creator.

License

CC BY

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.